XLVS.L vs. BTEK.L
Compare and contrast key facts about Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L).
XLVS.L and BTEK.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XLVS.L is a passively managed fund by Invesco that tracks the performance of the S&P® Select Sector Capped 20% Health Care Index. It was launched on Dec 16, 2009. BTEK.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Oct 19, 2017. Both XLVS.L and BTEK.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
XLVS.L vs. BTEK.L - Performance Comparison
Loading graphics...
XLVS.L vs. BTEK.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XLVS.L Invesco Health Care S&P US Select Sector UCITS ETF Acc | -4.71% | 14.78% | 2.15% | 1.56% | -2.62% | 27.57% | 12.04% | 20.54% | 4.30% | 0.89% |
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF | 3.48% | 33.15% | -1.98% | 5.62% | -12.08% | -0.02% | 26.88% | 26.51% | -11.65% | -0.56% |
Different Trading Currencies
XLVS.L is traded in USD, while BTEK.L is traded in GBP. To make them comparable, the BTEK.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, XLVS.L achieves a -4.71% return, which is significantly lower than BTEK.L's 3.48% return.
XLVS.L
- 1D
- 1.78%
- 1M
- -6.39%
- YTD
- -4.71%
- 6M
- 4.80%
- 1Y
- 3.47%
- 3Y*
- 6.07%
- 5Y*
- 6.19%
- 10Y*
- 9.53%
BTEK.L
- 1D
- 2.16%
- 1M
- -1.28%
- YTD
- 3.48%
- 6M
- 17.40%
- 1Y
- 39.67%
- 3Y*
- 13.39%
- 5Y*
- 4.65%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XLVS.L vs. BTEK.L - Expense Ratio Comparison
XLVS.L has a 0.14% expense ratio, which is lower than BTEK.L's 0.35% expense ratio.
Return for Risk
XLVS.L vs. BTEK.L — Risk / Return Rank
XLVS.L
BTEK.L
XLVS.L vs. BTEK.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XLVS.L | BTEK.L | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.20 | 1.78 | -1.58 |
Sortino ratioReturn per unit of downside risk | 0.40 | 2.38 | -1.98 |
Omega ratioGain probability vs. loss probability | 1.05 | 1.31 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | 0.39 | 3.23 | -2.84 |
Martin ratioReturn relative to average drawdown | 0.83 | 14.20 | -13.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XLVS.L | BTEK.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.20 | 1.78 | -1.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.43 | 0.22 | +0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.62 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.63 | 0.31 | +0.32 |
Correlation
The correlation between XLVS.L and BTEK.L is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
XLVS.L vs. BTEK.L - Dividend Comparison
Neither XLVS.L nor BTEK.L has paid dividends to shareholders.
Drawdowns
XLVS.L vs. BTEK.L - Drawdown Comparison
The maximum XLVS.L drawdown since its inception was -26.88%, smaller than the maximum BTEK.L drawdown of -38.25%. Use the drawdown chart below to compare losses from any high point for XLVS.L and BTEK.L.
Loading graphics...
Drawdown Indicators
| XLVS.L | BTEK.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.88% | -30.86% | +3.98% |
Max Drawdown (1Y)Largest decline over 1 year | -10.69% | -12.96% | +2.27% |
Max Drawdown (5Y)Largest decline over 5 years | -17.56% | -30.86% | +13.30% |
Max Drawdown (10Y)Largest decline over 10 years | -26.88% | — | — |
Current DrawdownCurrent decline from peak | -7.16% | -1.07% | -6.09% |
Average DrawdownAverage peak-to-trough decline | -4.85% | -10.18% | +5.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.95% | 2.86% | +2.09% |
Volatility
XLVS.L vs. BTEK.L - Volatility Comparison
The current volatility for Invesco Health Care S&P US Select Sector UCITS ETF Acc (XLVS.L) is 4.65%, while iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) has a volatility of 7.65%. This indicates that XLVS.L experiences smaller price fluctuations and is considered to be less risky than BTEK.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XLVS.L | BTEK.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.65% | 7.65% | -3.00% |
Volatility (6M)Calculated over the trailing 6-month period | 9.65% | 14.29% | -4.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.31% | 22.23% | -4.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.54% | 21.13% | -6.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.44% | 22.33% | -6.89% |